Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus

Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus
复制标题

DOI:
10.1136/jnnp.2005.069583
复制
发表时间:
2006-03-01
影响因子:
11
通讯作者:
Scheltens, P
Scheltens, P
中科院分区:
医学1区
文献类型:
--
作者:
Biessels, GJ;De Leeuw, FE;Scheltens, P

文献摘要

被引文献

相似文献

背景:2型糖尿病(DM 2)患者患阿尔茨海默病(AD)的风险增加。这种风险增加归因于血管合并症,但也涉及其他机制,例如大脑加速老化。目的:确定DM 2患者的AD是否与大脑血管病变发生率增加有关,通过增加脑萎缩,或两者的组合。方法:总共有29例AD和DM 2患者和58例AD和非DM 2患者被纳入研究。记录临床特征,并进行神经心理学检查和磁共振成像(MRI)扫描。MRI扫描被评为皮质和皮质下萎缩,内侧颞叶萎缩,白色物质病变,和infarcts.Results:两组的神经心理概况是相同的。与非DM 2组相比,AD和DM 2患者在MRI上的皮质萎缩增加(p < 0.05)。此外,梗死更常见(比值比2.4; 95% CI 0.8 - 7.8),但这种影响不能解释萎缩增加。其他MR措施之间没有差异groups.Conclusion:结果表明,非血管机制,导致增加皮质萎缩,也参与了AD的风险增加DM 2。
Background: The risk of Alzheimer's disease ( AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated.Objective: To determine whether AD in patients with DM2 is associated with an increased occurrence of vascular lesions in the brain, by increased cerebral atrophy, or a combination of both.Methods: In total, 29 patients with AD and DM2 and 58 patients with AD and without DM2 were included in the study. Clinical characteristics were recorded, and a neuropsychological examination and magnetic resonance imaging (MRI) scan were performed. MRI scans were rated for cortical and subcortical atrophy, medial temporal lobe atrophy, white matter lesions, and infarcts.Results: The neuropsychological profiles of the two groups were identical. Patients with AD and DM2 had increased cortical atrophy on MRI (p < 0.05) compared with the non-DM2 group. In addition, infarcts were more common ( odds ratio 2.4; 95% CI 0.8 to 7.8), but this effect did not account for the increased atrophy. The other MR measures did not differ between the groups.Conclusion: The results suggest that non-vascular mechanisms, leading to increased cortical atrophy, are also involved in the increased risk of AD in DM2.